PRO 140 700

Drug identity checked against registry records

Also recorded as leronlimab

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 StudyNCT05271370CytoDyn, Inc.Phase 2, Phase 3Terminated2022-06-20Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.